Profound Medical (PROF) Earnings Call Presentation

Incision-Free Ablative Intervention With Vision TULSA – A real-time imaging guided therapy platform for ablation of prostate tissue malignant or benign Corporate Presentation | May 2025 © 2025 Profound Medical Corp. NASDAQ: PROF, TSX: PRN 1 • FDA cleared in August 2019; first commercial site in January 2020, AI assistant cleared in May 2024 • Using patient cash pay business model installed >50 sites, >3,000 patients treated • New reimbursement codes established by AMA, placed by CMS in urology Level 7, effe ...